MF Afragil® in the treatment of 34 menopause symptoms: a pilot study.

Abstract

MF Afragil® was found to be efficient in reducing climacteric symptoms following a short-term administration. More prolonged treatment and more cases are under analysis to also determine its effect on osteroporosis.